SlideShare a Scribd company logo
1 of 18
Mr. SAJID HUSSAIN
(Asst. Professor)
S.R. Institute of Pharmacy
Bhuta, Bareilly (UP)
PROTEIN
ENGINEERING
⦿Protein engineering can be defined as
the modification of protein structure with
recombinant DNA technology or
chemical treatment to get a desirable
function for better use in medicine,
industry and agriculture.
OBJECTIVES OF PROTEIN
ENGINEERING
⦿The objectives of protein engineering is as
follows –
(a)to create a superior enzyme to
catalyze the production of high value
specific chemicals.
(b) to produce enzyme in large quantities.
(c)to produce biological
compounds(include synthetic peptide,
storage protein, and synthetic drugs)
superior to natural one.
⦿In view of above, the enzyme should be
engineered to meet the altered needs.
Therefore efforts have been made to
alter the properties of enzymes.
⦿These are some character that one
might have to change in a predictable
manner in protein engineering or
enzyme engineering to get the desired
function :-
⦿Kinetic properties of enzyme-turnover
and Michaelis constant, Km.
⦿Thermo stability and the optimum
temperature for the enzyme.
⦿Stability and activity of enzyme in
nonaqueous solvents.
⦿Substrate and reaction specificity.
⦿Cofactor requirements
⦿ Optimum PH.
⦿ Molecular weight and subunit structure.
⦿Therefore for a particular class of
enzymes, variation in nature may occur
for each of the above properties, so that
one may like to combine all the optimum
properties to the most efficient form of
the enzyme.
⦿For an e.g. glucose isomerases, which
convert glucose into other isomers like
fructose and are used to make high
fructose corn syrup vital for soft drink
industries.
Basic assumption for protein engineering
⦿ While doing protein engineering should
recognize the following properties of
enzymes,
⚫ many amino acid substitution, deletions or
additions lead to no changes in enzyme activity
so that they are silent mutator.
⚫ Protein have limited number of basic structures
and only minor changes are superimposed on
them leading to variation
⚫ Similar patterns of chain folding and domain
structure can arise from different amino acid
sequences with little or no homology.
Steps involved in protein
engineering
⦿A study of three dimensional structure of
protein :-
A study of three dimensional structure
is the preliminary steps of protein
engineering.And a 3d structure of
protein is produced from the data
generated from X-ray crystallography
and NMR process by protein modeling.
Methods for protein engineering
⦿A variety of methods are used in protein
engineering such as
mutagenesis, selection and recombinant
DNAtechnology.
Mutagenesis
⦿ Mutagenesis and selection can be
effectively utilized fro improving a specific
property of an enzyme.
⦿ E.g. for E.coli anthranilate synthetase
enzyme is normally sensitive to tryptophan
inhibitor due to feedback inhibition but an
altered MTR2 mutation of E.coli was found
to possess an altered form of enzyme
anthranilate synthetase that is insensitive
to tryptophan inhibition. And thus helping in
the continuous synthesis of tryptophan
without inhibition.
Mutagenesis
The two process of gene modification are-
(a) In vitro mutagenesis using synthetic
oligonucleotides.
(b) Synthesis of complete modified gene
de novo.
(a) In vitro mutagenesis using synthetic
oligonucleotides.
⦿ Synthetic oligonucleotides is used for
invitro mutagenesis. In this method a small
oligonucleotides primer containing the
desired modification is first synthesized. It
is then hybridized to the appropriate site
and cloned gene and then the rest is
replicated using DNA polymerase
enzyme, so that the rest remains unaltered.
This approach is actually used to modify
the active site of the tyrosyl-tRNA
synthetase
Synthesis of complete modified gene de
novo.
⦿Complete gene in some cases have
been chemically synthesized in the form
of several oligomers (e.g. genes for
insulin, somatostain and interferon), that
are ligated in correct order to produce a
complete gene. The sequence of the
synthetic gene can be designed in a
modular fashion to get the desired
function.
Chemical modification of
enzymes
⦿ The protein synthesized under the control
of gene sequence in a cell undergo post-
transitional modification. This leads to
stability, structural integrity, altered
solubility and viscosity of individual
proteins.
for e.g. Enzyme-PEG conjugates. An
enzyme L-asparaginase has antitumour
properties but is toxic with a life time of less
then 18hrs thus reducing its utility. L-
asparginase can be modified by
polyethene glycol derivatives to produce
PEG-asparginase conjugates, which differ
from the native enzyme in the following
way (i) it retains only 52% of the
catalytic activity of the native. (ii) it
become resistant to proteolytic
degradation. (iii) it doesn’t cause allergy.
Achievements of protein
engineering
⦿A number of proteins are known now
where efforts have been made to know
the effects of site specific mutagenesis
involving substitution of one or more
amino acids.
Insulin- it consist of A and B chains
are linked by C-peptide of 35 amino
acids. It was shown that a sequence of 6
amino acids for c-peptide was adequate
for the linking function.
cytochrome c – A phenylalanine residue
has been identified to be non-essential
for electron transfer but is involved in
determining the reduction potential of
the protein.
Trypsin- It could be redesigned to have
altered substrate specificity.
Protein Engineering.pptx

More Related Content

Similar to Protein Engineering.pptx

BMB 422 site directed mutag.-1.ppt
BMB 422 site directed mutag.-1.pptBMB 422 site directed mutag.-1.ppt
BMB 422 site directed mutag.-1.pptMUHAMMEDBAWAYUSUF
 
Engineered enzymes and their applicationsppt.pptx
Engineered enzymes and their applicationsppt.pptxEngineered enzymes and their applicationsppt.pptx
Engineered enzymes and their applicationsppt.pptxAdeeshRawat
 
protein engineering and site directed mutagenesis
  protein engineering and site directed mutagenesis  protein engineering and site directed mutagenesis
protein engineering and site directed mutagenesisNawfal Aldujaily
 
Metabolic engineering ppt
Metabolic engineering pptMetabolic engineering ppt
Metabolic engineering pptSatyam singh
 
Protein Engineering.pptx
Protein Engineering.pptxProtein Engineering.pptx
Protein Engineering.pptxTejaswiniAsawa
 
Recombinant Proteins
Recombinant ProteinsRecombinant Proteins
Recombinant ProteinsAmith Reddy
 
Post translational modification of protein
Post translational modification of proteinPost translational modification of protein
Post translational modification of proteincoolsid13
 
Protein engineering and its techniques himanshu
Protein engineering and its techniques himanshuProtein engineering and its techniques himanshu
Protein engineering and its techniques himanshuhimanshu kamboj
 
Suppressor mutation
Suppressor mutationSuppressor mutation
Suppressor mutationDeepika Rana
 
Protein Engineering - Ashvini.pptx
Protein Engineering - Ashvini.pptxProtein Engineering - Ashvini.pptx
Protein Engineering - Ashvini.pptxAshviniSoyam
 
Directed Evolution
Directed EvolutionDirected Evolution
Directed EvolutionIfrah Ishaq
 
Enzyme engineering by tamizh
Enzyme engineering by tamizhEnzyme engineering by tamizh
Enzyme engineering by tamizhTamizh Muhilan
 
Enzyme engineering .pdf
Enzyme engineering .pdfEnzyme engineering .pdf
Enzyme engineering .pdfAnukrittiMehra
 
Future Perspective of PROTAC Combined With CRISPR In Anti-ancer Area.pdf
Future Perspective of PROTAC Combined With CRISPR In Anti-ancer Area.pdfFuture Perspective of PROTAC Combined With CRISPR In Anti-ancer Area.pdf
Future Perspective of PROTAC Combined With CRISPR In Anti-ancer Area.pdfDoriaFang
 
Expression systems
Expression systemsExpression systems
Expression systemsankit
 
Strain improvement in microbial genetics .pptx
Strain improvement in microbial genetics .pptxStrain improvement in microbial genetics .pptx
Strain improvement in microbial genetics .pptxHamdiMichaelCC
 

Similar to Protein Engineering.pptx (20)

Site-Directed-Mutagenesis.pptx
Site-Directed-Mutagenesis.pptxSite-Directed-Mutagenesis.pptx
Site-Directed-Mutagenesis.pptx
 
BMB 422 site directed mutag.-1.ppt
BMB 422 site directed mutag.-1.pptBMB 422 site directed mutag.-1.ppt
BMB 422 site directed mutag.-1.ppt
 
Engineered enzymes and their applicationsppt.pptx
Engineered enzymes and their applicationsppt.pptxEngineered enzymes and their applicationsppt.pptx
Engineered enzymes and their applicationsppt.pptx
 
protein engineering and site directed mutagenesis
  protein engineering and site directed mutagenesis  protein engineering and site directed mutagenesis
protein engineering and site directed mutagenesis
 
Metabolic engineering ppt
Metabolic engineering pptMetabolic engineering ppt
Metabolic engineering ppt
 
Strain improvement
Strain improvementStrain improvement
Strain improvement
 
Protein Engineering.pptx
Protein Engineering.pptxProtein Engineering.pptx
Protein Engineering.pptx
 
Recombinant Proteins
Recombinant ProteinsRecombinant Proteins
Recombinant Proteins
 
Post translational modification of protein
Post translational modification of proteinPost translational modification of protein
Post translational modification of protein
 
Protein engineering and its techniques himanshu
Protein engineering and its techniques himanshuProtein engineering and its techniques himanshu
Protein engineering and its techniques himanshu
 
Suppressor mutation
Suppressor mutationSuppressor mutation
Suppressor mutation
 
Protein Engineering - Ashvini.pptx
Protein Engineering - Ashvini.pptxProtein Engineering - Ashvini.pptx
Protein Engineering - Ashvini.pptx
 
Directed Evolution
Directed EvolutionDirected Evolution
Directed Evolution
 
Enzyme engineering by tamizh
Enzyme engineering by tamizhEnzyme engineering by tamizh
Enzyme engineering by tamizh
 
Enzyme engineering .pdf
Enzyme engineering .pdfEnzyme engineering .pdf
Enzyme engineering .pdf
 
Future Perspective of PROTAC Combined With CRISPR In Anti-ancer Area.pdf
Future Perspective of PROTAC Combined With CRISPR In Anti-ancer Area.pdfFuture Perspective of PROTAC Combined With CRISPR In Anti-ancer Area.pdf
Future Perspective of PROTAC Combined With CRISPR In Anti-ancer Area.pdf
 
Biotransformation
BiotransformationBiotransformation
Biotransformation
 
Peptidomimetics
PeptidomimeticsPeptidomimetics
Peptidomimetics
 
Expression systems
Expression systemsExpression systems
Expression systems
 
Strain improvement in microbial genetics .pptx
Strain improvement in microbial genetics .pptxStrain improvement in microbial genetics .pptx
Strain improvement in microbial genetics .pptx
 

More from SajidHussain495712

Topical Preparation- Cream Ointments, paste etc.pptx
Topical Preparation- Cream Ointments, paste etc.pptxTopical Preparation- Cream Ointments, paste etc.pptx
Topical Preparation- Cream Ointments, paste etc.pptxSajidHussain495712
 
liquids preparations for oral administration
liquids preparations for oral administrationliquids preparations for oral administration
liquids preparations for oral administrationSajidHussain495712
 
Mucolytics, Expectorants, Antitussives & Bronchodialators.pptx
Mucolytics, Expectorants, Antitussives & Bronchodialators.pptxMucolytics, Expectorants, Antitussives & Bronchodialators.pptx
Mucolytics, Expectorants, Antitussives & Bronchodialators.pptxSajidHussain495712
 
Capsules and its type & evaluation.pptx
Capsules and its type &  evaluation.pptxCapsules and its type &  evaluation.pptx
Capsules and its type & evaluation.pptxSajidHussain495712
 
Capsules Manufacturing in Pharmacy .pptx
Capsules Manufacturing in Pharmacy .pptxCapsules Manufacturing in Pharmacy .pptx
Capsules Manufacturing in Pharmacy .pptxSajidHussain495712
 
Drugs used in ischemia (anti-anginal drug.pptx
Drugs used in ischemia (anti-anginal drug.pptxDrugs used in ischemia (anti-anginal drug.pptx
Drugs used in ischemia (anti-anginal drug.pptxSajidHussain495712
 
drugs used in high BP-anti-hypertensive drugs.pptx
drugs used in high BP-anti-hypertensive drugs.pptxdrugs used in high BP-anti-hypertensive drugs.pptx
drugs used in high BP-anti-hypertensive drugs.pptxSajidHussain495712
 
non-aqueous-titration FOR PHARM ANALYSIS.pptx
non-aqueous-titration FOR PHARM ANALYSIS.pptxnon-aqueous-titration FOR PHARM ANALYSIS.pptx
non-aqueous-titration FOR PHARM ANALYSIS.pptxSajidHussain495712
 
PRECIPITATION TITRATION IN PHARM ANALYSIS
PRECIPITATION TITRATION IN PHARM ANALYSISPRECIPITATION TITRATION IN PHARM ANALYSIS
PRECIPITATION TITRATION IN PHARM ANALYSISSajidHussain495712
 
complexometric titration, pharmaceutical analysis
complexometric titration, pharmaceutical analysiscomplexometric titration, pharmaceutical analysis
complexometric titration, pharmaceutical analysisSajidHussain495712
 
Applications of rDNA technology.pdf
Applications of rDNA technology.pdfApplications of rDNA technology.pdf
Applications of rDNA technology.pdfSajidHussain495712
 

More from SajidHussain495712 (18)

Topical Preparation- Cream Ointments, paste etc.pptx
Topical Preparation- Cream Ointments, paste etc.pptxTopical Preparation- Cream Ointments, paste etc.pptx
Topical Preparation- Cream Ointments, paste etc.pptx
 
liquids preparations for oral administration
liquids preparations for oral administrationliquids preparations for oral administration
liquids preparations for oral administration
 
Mucolytics, Expectorants, Antitussives & Bronchodialators.pptx
Mucolytics, Expectorants, Antitussives & Bronchodialators.pptxMucolytics, Expectorants, Antitussives & Bronchodialators.pptx
Mucolytics, Expectorants, Antitussives & Bronchodialators.pptx
 
Capsules and its type & evaluation.pptx
Capsules and its type &  evaluation.pptxCapsules and its type &  evaluation.pptx
Capsules and its type & evaluation.pptx
 
Capsules Manufacturing in Pharmacy .pptx
Capsules Manufacturing in Pharmacy .pptxCapsules Manufacturing in Pharmacy .pptx
Capsules Manufacturing in Pharmacy .pptx
 
Drugs used in ischemia (anti-anginal drug.pptx
Drugs used in ischemia (anti-anginal drug.pptxDrugs used in ischemia (anti-anginal drug.pptx
Drugs used in ischemia (anti-anginal drug.pptx
 
drugs used in high BP-anti-hypertensive drugs.pptx
drugs used in high BP-anti-hypertensive drugs.pptxdrugs used in high BP-anti-hypertensive drugs.pptx
drugs used in high BP-anti-hypertensive drugs.pptx
 
non-aqueous-titration FOR PHARM ANALYSIS.pptx
non-aqueous-titration FOR PHARM ANALYSIS.pptxnon-aqueous-titration FOR PHARM ANALYSIS.pptx
non-aqueous-titration FOR PHARM ANALYSIS.pptx
 
PRECIPITATION TITRATION IN PHARM ANALYSIS
PRECIPITATION TITRATION IN PHARM ANALYSISPRECIPITATION TITRATION IN PHARM ANALYSIS
PRECIPITATION TITRATION IN PHARM ANALYSIS
 
complexometric titration, pharmaceutical analysis
complexometric titration, pharmaceutical analysiscomplexometric titration, pharmaceutical analysis
complexometric titration, pharmaceutical analysis
 
PCR.pdf
PCR.pdfPCR.pdf
PCR.pdf
 
Enzymes immobilization.pdf
Enzymes immobilization.pdfEnzymes immobilization.pdf
Enzymes immobilization.pdf
 
Brain stem.pdf
Brain stem.pdfBrain stem.pdf
Brain stem.pdf
 
Vaccine storage.pdf
Vaccine storage.pdfVaccine storage.pdf
Vaccine storage.pdf
 
Biosensors.pdf
Biosensors.pdfBiosensors.pdf
Biosensors.pdf
 
Biosensors.pptx
Biosensors.pptxBiosensors.pptx
Biosensors.pptx
 
Applications of rDNA technology.pdf
Applications of rDNA technology.pdfApplications of rDNA technology.pdf
Applications of rDNA technology.pdf
 
Gravimetric Analysis.pptx
Gravimetric Analysis.pptxGravimetric Analysis.pptx
Gravimetric Analysis.pptx
 

Recently uploaded

Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfciinovamais
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 

Recently uploaded (20)

Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 

Protein Engineering.pptx

  • 1. Mr. SAJID HUSSAIN (Asst. Professor) S.R. Institute of Pharmacy Bhuta, Bareilly (UP)
  • 2. PROTEIN ENGINEERING ⦿Protein engineering can be defined as the modification of protein structure with recombinant DNA technology or chemical treatment to get a desirable function for better use in medicine, industry and agriculture.
  • 3. OBJECTIVES OF PROTEIN ENGINEERING ⦿The objectives of protein engineering is as follows – (a)to create a superior enzyme to catalyze the production of high value specific chemicals. (b) to produce enzyme in large quantities. (c)to produce biological compounds(include synthetic peptide, storage protein, and synthetic drugs) superior to natural one.
  • 4. ⦿In view of above, the enzyme should be engineered to meet the altered needs. Therefore efforts have been made to alter the properties of enzymes. ⦿These are some character that one might have to change in a predictable manner in protein engineering or enzyme engineering to get the desired function :-
  • 5. ⦿Kinetic properties of enzyme-turnover and Michaelis constant, Km. ⦿Thermo stability and the optimum temperature for the enzyme. ⦿Stability and activity of enzyme in nonaqueous solvents. ⦿Substrate and reaction specificity. ⦿Cofactor requirements ⦿ Optimum PH. ⦿ Molecular weight and subunit structure.
  • 6. ⦿Therefore for a particular class of enzymes, variation in nature may occur for each of the above properties, so that one may like to combine all the optimum properties to the most efficient form of the enzyme. ⦿For an e.g. glucose isomerases, which convert glucose into other isomers like fructose and are used to make high fructose corn syrup vital for soft drink industries.
  • 7. Basic assumption for protein engineering ⦿ While doing protein engineering should recognize the following properties of enzymes, ⚫ many amino acid substitution, deletions or additions lead to no changes in enzyme activity so that they are silent mutator. ⚫ Protein have limited number of basic structures and only minor changes are superimposed on them leading to variation ⚫ Similar patterns of chain folding and domain structure can arise from different amino acid sequences with little or no homology.
  • 8. Steps involved in protein engineering ⦿A study of three dimensional structure of protein :- A study of three dimensional structure is the preliminary steps of protein engineering.And a 3d structure of protein is produced from the data generated from X-ray crystallography and NMR process by protein modeling.
  • 9. Methods for protein engineering ⦿A variety of methods are used in protein engineering such as mutagenesis, selection and recombinant DNAtechnology.
  • 10. Mutagenesis ⦿ Mutagenesis and selection can be effectively utilized fro improving a specific property of an enzyme. ⦿ E.g. for E.coli anthranilate synthetase enzyme is normally sensitive to tryptophan inhibitor due to feedback inhibition but an altered MTR2 mutation of E.coli was found to possess an altered form of enzyme anthranilate synthetase that is insensitive to tryptophan inhibition. And thus helping in the continuous synthesis of tryptophan without inhibition.
  • 11. Mutagenesis The two process of gene modification are- (a) In vitro mutagenesis using synthetic oligonucleotides. (b) Synthesis of complete modified gene de novo.
  • 12. (a) In vitro mutagenesis using synthetic oligonucleotides. ⦿ Synthetic oligonucleotides is used for invitro mutagenesis. In this method a small oligonucleotides primer containing the desired modification is first synthesized. It is then hybridized to the appropriate site and cloned gene and then the rest is replicated using DNA polymerase enzyme, so that the rest remains unaltered. This approach is actually used to modify the active site of the tyrosyl-tRNA synthetase
  • 13. Synthesis of complete modified gene de novo. ⦿Complete gene in some cases have been chemically synthesized in the form of several oligomers (e.g. genes for insulin, somatostain and interferon), that are ligated in correct order to produce a complete gene. The sequence of the synthetic gene can be designed in a modular fashion to get the desired function.
  • 14. Chemical modification of enzymes ⦿ The protein synthesized under the control of gene sequence in a cell undergo post- transitional modification. This leads to stability, structural integrity, altered solubility and viscosity of individual proteins. for e.g. Enzyme-PEG conjugates. An enzyme L-asparaginase has antitumour properties but is toxic with a life time of less then 18hrs thus reducing its utility. L- asparginase can be modified by polyethene glycol derivatives to produce
  • 15. PEG-asparginase conjugates, which differ from the native enzyme in the following way (i) it retains only 52% of the catalytic activity of the native. (ii) it become resistant to proteolytic degradation. (iii) it doesn’t cause allergy.
  • 16. Achievements of protein engineering ⦿A number of proteins are known now where efforts have been made to know the effects of site specific mutagenesis involving substitution of one or more amino acids. Insulin- it consist of A and B chains are linked by C-peptide of 35 amino acids. It was shown that a sequence of 6 amino acids for c-peptide was adequate for the linking function.
  • 17. cytochrome c – A phenylalanine residue has been identified to be non-essential for electron transfer but is involved in determining the reduction potential of the protein. Trypsin- It could be redesigned to have altered substrate specificity.